Jennifer Crombie, MD, Dana-Farber Cancer Institute, Boston, Massachusetts, discusses results from a real-world study of lisocabtagene maraleucel in patients with relapsed/refractory large B-cell lymphoma. Similar to published findings…
Tanya Siddiqi, MD, medical director of lymphoma, City of Hope, Orange County, California, discusses the primary analysis of the TRANSCEND CLL 004 trial. This phase 1/2, single-arm, multicenter…
Brian Shuch, MD, director of the UCLA Kidney Cancer Program, explains what to expect after a radical nephrectomy. The procedure can be done minimally invasively, either laparoscopically or robotically,…
Heather N. Reich, MD, CM, PhD, FRCPC, Oreopoulos-Baxter Division Director of Nephrology, University of Toronto, discusses translating new clinical trials in IgA nephropathy, a kidney disease. Dr Reich…
Diana Girnita, MD, PhD, founder of Rheumatologist OnCall, discusses who should exercise, when to exercise, and where to exercise. Melissa Koehl, PT, DPT, introduces the 10 best exercises…
April W. Armstrong, MD, MPH, of @KeckMedUSC, and Erin E. Boh, MD, PhD, of @TulaneMedicine, discuss the use of IL-23 and IL-17 inhibitors in #psoriaticdisease.
